Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

247.22
Delayed Data
As of Feb 12
 +2.11 / +0.86%
Today’s Change
242.07
Today|||52-Week Range
480.18
-19.30%
Year-to-Date

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for Biogen have a median target of 351.50, with a high estimate of 450.00 and a low estimate of 292.00. The median estimate represents a +42.18% increase from the last price of 247.22.

Analyst Recommendations

The current consensus among 25 polled investment analysts is to Buy stock in Biogen. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$4.46
Sales
$2.8B
Reporting Date
Apr 21

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.85%
 
 
 
 
 
 
Growthannually 9.52%
 
 
 
 
 
 

Sales

Growthquarterly -3.01%
 
 
 
 
 
 
Growthannually 5.36%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.